Podcast
ACCP JOURNALS
Hosted by ACCP JOURNALS · EN
This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice.
ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.
21episodes
Episodes
Newest firstAll episodes
Ambient AI use in Ambulatory Pharmacy Clinical Practice - Ep 187
Jul 1400:36:15Tap to summarizeDrs. Alan Zillich and Khoa Nguyen speak with Drs. Kathryn Lin and Morgan Stewart (University of Texas at Austin) and Dr. Tony Olson (Geisinger) about clinical pharmacists using ambientAI documentation tools in ambulatory care. The guests describe workflows using mobile apps integrated with Epic, consent processes, and pharmacist review/editing before signing notes. They discuss implementation rollouts,benefits such as reduced documentation burden, improved attention during encounters, less after-hours work, and support for bilingual Spanish-English visits, as well as challenges like inaccuracies, paraphrasing, and considerations for training student learners. Listen as they summarize their study findings and read the full manuscript here: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70242.
Transcribe →
Comparative Analysis of Nafcillin and Oxacillin: Implications for MSSA Treatment - Ep 186
Jul 900:21:57Tap to summarizeHost Dr. Michael Rybak interviews Drs. Alejandro Perez and Autumn Brenner (UNC Medical Center) about their retrospective study, “Incidence of Acute Kidney Injury with the Use of Nafcillin versus Oxacillin,” comparing 171 nafcillin patients with 467 oxacillin patients. The study found a higher AKI rate with nafcillin (33.3%) versus oxacillin (19.5%), along with higher hypokalemia, suggesting these agents may not be clinically interchangeable from a safety standpoint. They discuss confounding concerns around observed mortality and length-of-stay differences, offer mechanistic explanations, and recommend close monitoring of creatinine and potassium—especially in high-risk patients.
Transcribe →
Pharmacotherapy and AI: Beyond the Fear, Towards Collaboration - Ep 185
Jun 3000:19:58Tap to summarizeHost Dr. Tom Lodise interviews Dr. Marc Scheetz about his Pharmacotherapy editorial, “AI in ID Pharmacy: We Should Not Be Afraid to Put the CAR (Not the Cart) Before the Horse,” discussing how AI is already mainstream and increasingly used in healthcare. Scheetz uses the Industrial Revolution and the John Henry story to argue clinicians should not compete with machines but learn to make them work with us, as AI can outperform humans in many tasks. His optimistic view is that AI will reduce computer-bound work and preserve human connection in patient care. Read the full editorial at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70103
Transcribe →
Getting Published in JACCP: Tips for Success - Ep 184
Jun 900:27:54Tap to summarizeIn this episode of the JACCP Podcast, host Rob DiDomenico is joined by JACCP Editor in Chief Stuart Haines and Senior Associate Editor Beth Phillips to offer practical guidance for authors seeking to publish in the Journal of the American College of Clinical Pharmacy. With nearly 500 annual submissions and a rejection rate approaching 90% for unsolicited manuscripts, it’s important to put together a strong submission. The conversation covers the journal's scope and mission and addresses the most common reasons manuscripts are rejected, from methodological weaknesses to unsupported conclusions. Stuart and Beth also share actionable tips on following reporting guidelines, strengthening review articles, and exploring the journal's full range of manuscript types. A recurring theme: don't hesitate to pitch your idea before investing weeks in writing.
Transcribe →
Predicting Fall Risks in Older Adults with Depression: A Machine Learning Approach - Ep 183
May 1900:30:19Tap to summarizeDr. Ryan Carnahan, Pharmacotherapy's statistical scientific editor, interviews Dr. Jenny Lo-Ciganic about her research on the use of machine learning models to predict fall-related injuries among older adults with depression. Lo-Ciganic describes her work using real-world data and advanced analytics to improve medication safety and decision support. The discussion reviews the burden of falls and how depression increases risk, noting prior antidepressant–fall associations may reflect confounding by indication. They also address key injurious fall predictors, including frailty, age, prior falls, osteoarthritis, antidepressant dose, and regional social/health measures. Read the full manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/ftr/10.1002/phar.70087.
Transcribe →
Reimagining Renal Assessment: Pros and Cons - Ep 182
May 1200:37:40Tap to summarizeJACCP associate editor and host, Erica Ernst, interviews Drs. Wendy St. Peter and Barbara Zarowitz discuss adopting race-free estimated GFR (CKD-EPI) for medication-related kidney function assessment in older adults and other patient populations, as well as moving away from the Cockcroft–Gault equation. The discussion highlights deficiencies and variabilityin Cockcroft–Gault use, emerging studies where BSA-adjusted eGFR better predicts drug clearance, barriers to cystatin C access and Medicare coverage, and the need for further research, electronic health record integration, and advocacy across organizations. Read the original article and series of letters published in JACCP.
Transcribe →
Navigating Cardiotoxicity in Modern Cancer Therapy - Ep 181
Apr 2200:33:16Tap to summarizeIn this episode, Pharmacotherapy scientific editor Jim Koeller interviews hematology-oncology specialist Dennis Marjoncu about Dr. Marjoncu's narrative review article “Cancer Therapy-Induced Cardiotoxicity”. They discuss how cardiotoxicity concerns have expanded beyond anthracyclines. They review cardiotoxicity types, monitoring approaches, management principles, drug-interaction considerations, limited prevention data, guideline gaps, and the need for better risk stratification and trial-based cardiac data.
Transcribe →
High-Value Interventions Primary Care Practices Might Be Overlooking: Clinical Pharmacy Services – Ep 180
Apr 700:35:31Tap to summarizeThis podcast episode features an interview with Russell Phillips, Amie Pollack, and Dru Ricci from the Center for Primary Care at Harvard Medical School and authors of the Primary Care Investment Guide, with special guest, Todd Sorensen from the University of Minnesota College of Pharmacy. The Primary Care Investment Guide advocates for the integration of clinical pharmacists into primary care teams. The authors explain that their research used a mixed-methods approach, interviewing healthcare leaders from five states and conducting literature reviews, to identify sustainable strategies in primary care settings that enhance patient outcomes and reduce costs. Their findings highlight that clinical pharmacists provide a significant return on investment by managing chronic diseases, optimizing medications, improving medication access, and decreasing hospitalizations. The discussion emphasizes that successful integration can be facilitated by payment reform, moving away from fee-for-service models toward capitated payments and other alternative payment models that support optimal care delivery by primary care teams. Ultimately, the Guide provides a strategic framework for healthcare leaders and policymakers to justify and implement the provision of high-value services in primary care settings. Funding for the Primary Care Investment Guide was provided by The Commonwealth Fund and the California Health Care Foundation. You can download the Primary Care Investment Guide here: https://thepcc.org/reports/2025-primary-care-investment-guide/
Transcribe →
Enhancing Pharmacotherapy Through Artificial Intelligence: From Prediction Models to Practice – Ep 179
Mar 2500:23:52Tap to summarizeIn this episode of the Pharmacotherapy Podcast, host Dr. Lindsay DeVane speaks with Dr. William Baker and Dr. Alexandre Chan, guest editors of a themed issue on artificial intelligence (AI) in pharmacotherapy. The discussion explores how AI—particularly machine learning and large language models—isbeing used to predict drug response, improve safety, and streamline research and clinical workflows across diverse therapeutic areas. The guests address common concerns about trust, transparency, and clinician autonomy, emphasizingAI’s role as a supportive “copilot” rather than a replacement for clinical judgment. They also highlight current gaps and future opportunities, including pharmacogenomics, imaging data, and patient-reported outcomes, and offer practical advice for trainees and researchers seeking to build AI literacy through a combination of conceptual understanding, short courses, andcollaborative learning. Read the themed issue at: https://accpjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1875-9114.Enhancing-Pharmacotherapy-Through-AI
Transcribe →
A Medical Writing Rotation: Flipping the Odds on Resident Scholarship - Ep 178
Mar 1600:23:35Tap to summarizeToday we're discussing a medical writing rotation that achieved an impressive 87.5% publication success rate for its residents. Whether you’re a practitioner, faculty member, or program director looking to boost scholarship of residency projects or a resident who wants to gain valuable skills and make a lasting mark on medical literature, we’re going to talk about a strategy to turn that hard work into published impact. Read the full manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70157
Transcribe →